These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 34856222)

  • 1. Subthalamic burst firing: A pathophysiological target in Parkinson's disease.
    Tai CH
    Neurosci Biobehav Rev; 2022 Jan; 132():410-419. PubMed ID: 34856222
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Electrophysiology of subthalamic nucleus in normal and Parkinson's disease].
    Tai CH; Kuo CC
    Acta Neurol Taiwan; 2006 Sep; 15(3):206-16. PubMed ID: 16995602
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Basal ganglia neural responses during behaviorally effective deep brain stimulation of the subthalamic nucleus in rats performing a treadmill locomotion test.
    Shi LH; Luo F; Woodward DJ; Chang JY
    Synapse; 2006 Jun; 59(7):445-57. PubMed ID: 16521122
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Subthalamic nucleus: from circuits, functions to a deep brain stimulation target for the treatment of Parkinson's disease].
    Li GY; Zhuang QX; Li B; Wang JJ; Zhu JN
    Sheng Li Xue Bao; 2017 Oct; 69(5):611-622. PubMed ID: 29063109
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Subthalamic deep brain stimulation alters neuronal firing in canonical pain nuclei in a 6-hydroxydopamine lesioned rat model of Parkinson's disease.
    Gee LE; Walling I; Ramirez-Zamora A; Shin DS; Pilitsis JG
    Exp Neurol; 2016 Sep; 283(Pt A):298-307. PubMed ID: 27373204
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The T-type calcium channel as a new therapeutic target for Parkinson's disease.
    Yang YC; Tai CH; Pan MK; Kuo CC
    Pflugers Arch; 2014 Apr; 466(4):747-55. PubMed ID: 24531801
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An electrophysiological perspective on Parkinson's disease: symptomatic pathogenesis and therapeutic approaches.
    Lee LN; Huang CS; Chuang HH; Lai HJ; Yang CK; Yang YC; Kuo CC
    J Biomed Sci; 2021 Dec; 28(1):85. PubMed ID: 34886870
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synchronised spiking activity underlies phase amplitude coupling in the subthalamic nucleus of Parkinson's disease patients.
    Meidahl AC; Moll CKE; van Wijk BCM; Gulberti A; Tinkhauser G; Westphal M; Engel AK; Hamel W; Brown P; Sharott A
    Neurobiol Dis; 2019 Jul; 127():101-113. PubMed ID: 30753889
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Frequency-Specific Optogenetic Deep Brain Stimulation of Subthalamic Nucleus Improves Parkinsonian Motor Behaviors.
    Yu C; Cassar IR; Sambangi J; Grill WM
    J Neurosci; 2020 May; 40(22):4323-4334. PubMed ID: 32312888
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Network effects of subthalamic deep brain stimulation drive a unique mixture of responses in basal ganglia output.
    Humphries MD; Gurney K
    Eur J Neurosci; 2012 Jul; 36(2):2240-51. PubMed ID: 22805068
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Parkinson's disease and cortico-Basal Ganglia circuits].
    Pan MK; Tai CH; Kuo CC
    Acta Neurol Taiwan; 2010 Sep; 19(3):213-22. PubMed ID: 20824544
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oscillations of pause-burst neurons in the STN correlate with the severity of motor signs in Parkinson's disease.
    Belova EМ; Filyushkina VI; Dzhalagoniia I; Gamaleya AA; Tomskiy AA; Neumann WJ; Sedov A
    Exp Neurol; 2022 Oct; 356():114155. PubMed ID: 35772526
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Modeling parkinsonian circuitry and the DBS electrode. II. Evaluation of a computer simulation model of the basal ganglia with and without subthalamic nucleus stimulation.
    Shils JL; Mei LZ; Arle JE
    Stereotact Funct Neurosurg; 2008; 86(1):16-29. PubMed ID: 17881885
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Parkinsonian Beta Dynamics during Rest and Movement in the Dorsal Pallidum and Subthalamic Nucleus.
    Eisinger RS; Cagle JN; Opri E; Alcantara J; Cernera S; Foote KD; Okun MS; Gunduz A
    J Neurosci; 2020 Apr; 40(14):2859-2867. PubMed ID: 32107277
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Therapeutic deep brain stimulation disrupts movement-related subthalamic nucleus activity in parkinsonian mice.
    Schor JS; Gonzalez Montalvo I; Spratt PWE; Brakaj RJ; Stansil JA; Twedell EL; Bender KJ; Nelson AB
    Elife; 2022 Jul; 11():. PubMed ID: 35786442
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neuromodulation targets pathological not physiological beta bursts during gait in Parkinson's disease.
    Anidi C; O'Day JJ; Anderson RW; Afzal MF; Syrkin-Nikolau J; Velisar A; Bronte-Stewart HM
    Neurobiol Dis; 2018 Dec; 120():107-117. PubMed ID: 30196050
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Investigating Synchronous Oscillation and Deep Brain Stimulation Treatment in A Model of Cortico-Basal Ganglia Network.
    Lu M; Wei X; Loparo KA
    IEEE Trans Neural Syst Rehabil Eng; 2017 Nov; 25(11):1950-1958. PubMed ID: 28541214
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Frequency matters: beta-band subthalamic nucleus deep-brain stimulation induces Parkinsonian-like blink abnormalities in normal rats.
    Kaminer J; Thakur P; Evinger C
    Eur J Neurosci; 2014 Oct; 40(8):3237-42. PubMed ID: 25146113
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Subthalamic Deep Brain Stimulation Affects Plasma Corticosterone Concentration and Peripheral Immunity Changes in Rat Model of Parkinson's Disease.
    Grembecka B; Glac W; Listowska M; Jerzemowska G; Plucińska K; Majkutewicz I; Badtke P; Wrona D
    J Neuroimmune Pharmacol; 2021 Jun; 16(2):454-469. PubMed ID: 32648088
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Improving outcomes of subthalamic nucleus deep brain stimulation in Parkinson's disease.
    Bari AA; Fasano A; Munhoz RP; Lozano AM
    Expert Rev Neurother; 2015 Oct; 15(10):1151-60. PubMed ID: 26377740
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.